Max Glaser, MD
Nephrology · Kansas City, MONPI 1750370615
Payments from drug & device makers
Across 51 payments — averaging $32.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$855
- Medtronic$255
- Mozarc Medical US LLC$254
- Boston Scientific$99
- Amgen$52
- Mallinckrodt Hospital Products Inc.$23
- plus $102 from 6 others
What the payments were for
- Food & beverage$1,640100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 17 | $855 |
| Medtronic | 12 | $255 |
| Mozarc Medical US LLC | 7 | $254 |
| Boston Scientific | 5 | $99 |
| Amgen(2 entities) | 3 | $52 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Vifor Pharma, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $19 |
| Boehringer Ingelheim | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| La Jolla Pharmaceutical Company | 1 | $15 |
| G Medical Diagnostic Services, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,640 in reported general payments places this provider in the 60th percentile of 253 nephrology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 41 | $79,478 |
| Lanthanum Carbonate | 35 | $46,192 |
| Sevelamer Carbonate | 141 | $26,020 |
| VeltassaPatiromer Calcium Sorbitex | 13 | $22,056 |
| EliquisApixaban | 15 | $8,616 |
| LokelmaSodium Zirconium Cyclosilicate | 14 | $5,590 |
| Midodrine Hcl | 24 | $2,231 |
| Calcium Acetate | 16 | $1,916 |
| Isosorbide Dinitrate | 14 | $884 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 20 | $782 |
| Carvedilol | 88 | $763 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $599 |
| Hydralazine Hcl | 59 | $507 |
| Metoprolol Succinate | 40 | $344 |
| LoperamideLoperamide Hcl | 11 | $341 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Kansas City
- Ahmed AwadKansas City$12.4M
- Kelly AlfordKansas City$58K
- Tarek DarwishKansas City$52K
- Archana GoelKansas City$49K
- Richard CaplingKansas City$31K
- Thomas WiegmannKansas City$25K
- Jignesh ShahKansas City$7K
- Adnan KhanKansas City$7K
- Robert GolderKansas City$5K
- Benjamin HumphreysSaint Louis$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.